D
Diana Manolescu
Publications - 30
Citations - 168
Diana Manolescu is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 9 publications receiving 38 citations.
Papers
More filters
Journal ArticleDOI
The reliability of lung ultrasound in assessment of idiopathic pulmonary fibrosis
TL;DR: LUS is a repeatable, totally radiation-free procedure, well tolerated by patients, very sensitive in detecting early changes of fibrotic lung, and therefore a useful imaging technique in monitoring disease progression in the natural course or after initiation of treatment.
Journal ArticleDOI
Deep learning in interstitial lung disease-how long until daily practice.
TL;DR: This review describes computer-aided diagnosis systems centered on deep learning approaches that improve the diagnostic of interstitial lung diseases and highlights the challenges and the implementation of important daily practice in the early diagnosis of idiopathic pulmonary fibrosis.
Journal ArticleDOI
Impact of moderate to severe obstructive sleep apnea on the cognition in idiopathic pulmonary fibrosis.
Voicu Tudorache,Daniel Traila,Monica Marc,Cristian Oancea,Diana Manolescu,Emanuela Tudorache,Bogdan Timar,Alin Albai,Ovidiu Fira-Mladinescu +8 more
TL;DR: Impaired cognition in patients with IPF is mild and affect the areas of visuospatial abilities, language and working memory, and OSA could be a possible predictor of IPF cognition deficit.
Journal ArticleDOI
Using the NYHA Classification as Forecasting Tool for Hospital Readmission and Mortality in Heart Failure Patients with COVID-19
Ioana Mihaela Citu,Cosmin Citu,Florin Gorun,Radu Neamtu,Andrei Motoc,Bogdan Burlea,Ovidiu Roşca,Felix Bratosin,Samer Hosin,Diana Manolescu,Raul Patrascu,O. M. Gorun +11 more
TL;DR: This retrospective study aimed to determine the potential use of the NYHA classification for HF in hospitalized patients with COVID-19 as prognostic tool for in-hospital mortality, length of hospitalization, and probability of rehospitalization for HF decompensation and highlights that HF patients continue to be vulnerable post SARS-CoV-2 infection.
Journal ArticleDOI
Predictors for COVID-19 Complete Remission with HRCT Pattern Evolution: A Monocentric, Prospective Study
TL;DR: Chest HRCT is a “time window” in documenting temporal persistent radiologic features of lung injury 90 days after SARS-CoV-2 infection, determining the pathologic basis of so-called “long COVID”.